Amyloid precursor protein‐mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease
- 23 November 2005
- journal article
- review article
- Published by Wiley in Journal of Neurochemistry
- Vol. 96 (1), 1-13
- https://doi.org/10.1111/j.1471-4159.2005.03530.x
Abstract
Alzheimer's disease (AD) is a late-onset dementia that is characterized by the loss of memory and an impairment of multiple cognitive functions. Advancements in molecular, cellular, and animal model studies have revealed that the formation of amyloid beta (Abeta) and other derivatives of the amyloid precursor protein (APP) are key factors in cellular changes in the AD brain, including the generation of free radicals, oxidative damage, and inflammation. Recent molecular, cellular, and gene expression studies have revealed that Abeta enters mitochondria, induces the generation of free radicals, and leads to oxidative damage in post-mortem brain neurons from AD patients and in brain neurons from cell models and transgenic mouse models of AD. In the last three decades, tremendous progress has been made in mitochondrial research and has provided significant findings to link mitochondrial oxidative damage and neurodegenerative diseases such as AD. Researchers in the AD field are beginning to recognize the possible involvement of a mutant APP and its derivatives in causing mitochondrial oxidative damage in AD. This article summarizes the latest research findings on the generation of free radicals in mitochondria and provides a possible model that links Abeta proteins, the generation of free radicals, and oxidative damage in AD development and progression.Keywords
This publication has 104 references indexed in Scilit:
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoJournal of Biological Chemistry, 2005
- A “mitochondrial cascade hypothesis” for sporadic Alzheimer's diseaseMedical Hypotheses, 2004
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Effects of α-tocopherol on an animal model of tauopathiesFree Radical Biology & Medicine, 2004
- Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injuryJournal of Neurochemistry, 2004
- Ginkgo biloba Extract EGb 761® in Dementia: Intent-to-treat Analyses of a 24-week, Multi-center, Double-blind, Placebo-controlled, Randomized TrialPharmacopsychiatry, 2003
- The herbal medicine Dipsacus asper Wall extract reduces the cognitive deficits and overexpression of β-amyloid protein induced by aluminum exposureLife Sciences, 2003
- Pharmacological Studies Supporting the Therapeutic Use of Ginkgo biloba Extract for Alzheimer’s DiseasePharmacopsychiatry, 2003
- The NADPH Oxidase of Endothelial CellsIUBMB Life, 2000
- Oxidative damage in Alzheimer'sNature, 1996